MedPath
NMPA Approval

Potassium Sodium Dehydroandrographolide Succinate for Injection

国药准字H20064443

July 9, 2021

国药准字H20064443

Drug Information

注射用炎琥宁

修正

注射剂

200mg

化学药品

July 9, 2021

Company Information

Applicant Company

安徽省蚌埠市凤阳东路76号

Manufacturing Company

安徽省蚌埠市凤阳东路76号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用炎琥宁 - NMPA 批准文号 | MedPath